ICD-11 code 1F28.0 corresponds to Dermatophytosis of the scalp, a fungal infection that affects the skin on the head. This condition, also known as tinea capitis, is caused by various species of fungi called dermatophytes. Dermatophytosis of the scalp is commonly seen in children but can also occur in adults.
The main symptom of dermatophytosis of the scalp is the presence of round, scaly patches on the scalp that may be itchy and inflamed. In severe cases, hair loss and painful nodules can also occur. Diagnosis is typically made through a physical examination of the scalp and microscopic examination of skin scrapings.
Treatment for dermatophytosis of the scalp usually involves antifungal medications, such as oral griseofulvin or terbinafine, along with medicated shampoos or creams. It is important to follow the prescribed treatment regimen to ensure complete eradication of the fungal infection. Additionally, good hygiene practices and avoiding sharing personal items like hats and combs can help prevent the spread of dermatophytosis of the scalp.
Table of Contents:
- #️⃣ Coding Considerations
- 🔎 Symptoms
- 🩺 Diagnosis
- 💊 Treatment & Recovery
- 🌎 Prevalence & Risk
- 😷 Prevention
- 🦠 Similar Diseases
#️⃣ Coding Considerations
The equivalent SNOMED CT code for ICD-11 code 1F28.0 (Dermatophytosis of scalp) is 293962004. This code specifically identifies the condition of dermatophytosis affecting the scalp, which is a fungal infection that commonly causes hair loss and other symptoms. By using SNOMED CT, healthcare professionals can accurately document and communicate the diagnosis of dermatophytosis of the scalp in a standardized manner. This facilitates better coordination of care and research efforts across different healthcare settings and regions. Furthermore, the use of SNOMED CT enables electronic health records to capture detailed clinical information about the specific type and location of a patient’s dermatophytosis, aiding in treatment decisions and outcomes tracking.
In the United States, ICD-11 is not yet in use. The U.S. is currently using ICD-10-CM (Clinical Modification), which has been adapted from the WHO’s ICD-10 to better suit the American healthcare system’s requirements for billing and clinical purposes. The Centers for Medicare and Medicaid Services (CMS) have not yet set a specific date for the transition to ICD-11.
The situation in Europe varies by country. Some European nations are considering the adoption of ICD-11 or are in various stages of planning and pilot studies. However, as with the U.S., full implementation may take several years due to similar requirements for system updates and training.
🔎 Symptoms
Symptoms of Dermatophytosis of the scalp, also known as tinea capitis, typically include round, scaly patches that may be red or itchy. Hair loss or broken hairs within the affected area can also be observed. In some cases, there may be swollen lymph nodes near the scalp.
Fungal infection of the scalp can lead to the formation of kerion, a painful, boggy mass with pustules and draining sinus tracts. The scalp may become thickened and inflamed, with the appearance of black dots representing broken hairs. Additionally, patients with tinea capitis may experience a low-grade fever or malaise.
Other symptoms of tinea capitis may include a foul odor emanating from the scalp due to secondary bacterial infection. This infection can result in the presence of crusty, honey-colored lesions on the scalp. Patients may also experience excessive itching and, in severe cases, development of abscesses or cellulitis. Overall, timely and accurate diagnosis of tinea capitis is crucial for effective treatment and prevention of complications.
🩺 Diagnosis
Diagnosis methods for 1F28.0, also known as dermatophytosis of the scalp, typically involve a combination of physical examination, laboratory tests, and sometimes imaging studies. During the physical examination, the healthcare provider will inspect the scalp for signs of infection such as redness, scaling, hair loss, and inflammation. They may also use a specialized tool called a Wood’s lamp to help identify fungal infections by illuminating affected areas with a specific wavelength of light.
In addition to the physical examination, laboratory tests are often performed to confirm the diagnosis of dermatophytosis of the scalp. One common test is a fungal culture, where a sample of skin or hair from the affected area is collected and sent to a laboratory for analysis. The laboratory will attempt to grow the fungus in a culture medium and identify the specific species causing the infection. Other laboratory tests, such as a microscopic examination of skin scrapings or hair samples, may also be used to confirm the presence of dermatophytes.
In some cases, imaging studies such as a scalp biopsy may be recommended to help diagnose dermatophytosis of the scalp. During a scalp biopsy, a small piece of skin or hair follicle is removed and examined under a microscope to look for signs of fungal infection. This procedure can help confirm the diagnosis and determine the extent of the infection. Imaging studies like MRI or CT scans are typically not needed for the diagnosis of dermatophytosis of the scalp, but may be ordered if there are concerns about complications or spread of the infection to deeper tissues.
💊 Treatment & Recovery
Treatment for dermatophytosis of the scalp, also known as tinea capitis, typically involves antifungal medications. Oral medication such as griseofulvin or terbinafine is often prescribed to combat the infection from within the body. These medications work by inhibiting the growth of the fungus responsible for the infection.
In addition to oral medications, antifungal shampoos or creams may be recommended for topical treatment of the affected area. These products contain active ingredients such as ketoconazole or selenium sulfide, which help to alleviate symptoms and combat the fungal infection on the scalp.
It is imperative to continue treatment for the prescribed duration, even if symptoms improve before the medication is finished. Failure to complete the full course of treatment can result in a recurrence of the infection. It is also important to maintain good hygiene practices, such as regularly washing scalp and hair with anti-fungal shampoo, to prevent the spread of the infection to others.
🌎 Prevalence & Risk
In the United States, the prevalence of Dermatophytosis of the scalp, coded as 1F28.0, is estimated to be relatively low compared to other regions. This fungal infection primarily affects children, especially those of African-American descent. While exact prevalence rates are not readily available, cases are more commonly seen in urban areas with lower socioeconomic status.
In Europe, the prevalence of 1F28.0 varies by country and is generally considered to be higher than in the United States. Northern European countries such as Finland and Sweden have reported lower rates of Dermatophytosis of the scalp compared to Southern European countries like Italy and Greece. Factors such as climate, hygiene practices, and cultural factors may contribute to these regional differences in prevalence.
In Asia, the prevalence of Dermatophytosis of the scalp is relatively high, particularly in tropical regions with high humidity levels. Countries such as India, Indonesia, and the Philippines report a significant number of cases each year. Poor hygiene practices, crowded living conditions, and lack of access to healthcare services contribute to the higher prevalence rates in these regions.
In Africa, the prevalence of 1F28.0 is also significant, particularly in sub-Saharan countries where living conditions may be less than optimal. Factors such as poverty, limited access to clean water, and inadequate healthcare infrastructure contribute to the spread of this fungal infection. Additionally, cultural practices such as sharing combs and hair accessories may also contribute to the high prevalence of Dermatophytosis of the scalp in African countries.
😷 Prevention
To prevent Dermatophytosis of the scalp (1F28.0), it is important to practice good hygiene and maintain a clean environment. Avoid sharing personal items such as combs, hats, and towels with others to reduce the risk of spreading the infection. Regularly wash and dry your hair to keep the scalp clean and free from fungus.
Another way to prevent Dermatophytosis of the scalp is to avoid walking barefoot in communal areas such as locker rooms, showers, and swimming pools. Fungi that cause the infection can thrive in these warm, moist environments. Wear flip-flops or waterproof shoes to protect your feet from coming into contact with contaminated surfaces.
Additionally, it is important to treat any existing skin conditions such as eczema or psoriasis promptly, as these can increase the risk of developing Dermatophytosis of the scalp. Properly manage these conditions with the help of a healthcare provider to prevent further complications. practicing good overall hygiene, including washing your hands regularly and avoiding close contact with individuals who have fungal infections, can also help reduce the risk of contracting Dermatophytosis of the scalp.
🦠 Similar Diseases
Tinea capitis, also known as scalp ringworm, is a fungal infection that affects the scalp and hair shafts. The primary causative agents are dermatophytes, including Trichophyton and Microsporum species. Symptoms include itching, redness, scaling, and hair loss in affected areas. Tinea capitis is common in children, but can also affect adults.
ICD-10 code B35.0 (Tinea capitis) is used to classify cases of scalp ringworm in medical coding. This code is similar to 1F28.0 (Dermatophytosis of scalp) in terms of identifying fungal infections of the scalp. However, B35.0 specifically refers to tinea capitis caused by dermatophytes, whereas 1F28.0 may encompass a broader range of fungal scalp infections.
Seborrheic dermatitis is a chronic inflammatory skin condition that affects areas rich in sebaceous glands, such as the scalp, face, and chest. The exact cause of seborrheic dermatitis is unknown, but factors such as genetics, immune system dysfunction, and the presence of Malassezia yeast may play a role. Symptoms include redness, scaling, itching, and greasy patches on the skin.
ICD-10 code L21.0 (Seborrheic dermatitis) is used to classify cases of seborrheic dermatitis in medical coding. While seborrheic dermatitis primarily affects the scalp, it differs from 1F28.0 (Dermatophytosis of scalp) in terms of its underlying cause and clinical presentation. L21.0 is specifically assigned to cases of seborrheic dermatitis, whereas 1F28.0 is more focused on dermatophyte infections of the scalp.